Ergomed (ERGO)


Latest News

Holding(s) in Company

RNS Number: 4896T Ergomed plc 12 October 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Ergomed plc 1b. Please in...

Broker Forecast - Numis issues a broker note on Ergomed Plc

Numis today reaffirms its buy investment rating on Ergomed Plc (LON:ERGO) and set its price target at 280p.

Ergomed completes acquisition of PSR

Ergomed completed the acquisition of PSR Group BV following the admission to trading on AIM of the 2,081,389 new ordi...

Completion of Acquisition of PSR Group BV

RNS Number: 4800S Ergomed plc 03 October 2017 Ergomed plc Completion of Acquisition of PSR Group BV, a specialist orphan drug CRO London, UK - 3 October 2017: Ergomed plc (AIM: ERGO) ("Ergomed" or the "Company"), is pleased to announce that, further to the Company's announcement on 28 September 2017, the acquisition of PSR Group BV ("PSR") h...

All News

12-10-17Holding(s) in CompanyRNS
06-10-17Broker Forecast - Numis issues a broker note on Ergomed PlcStockMarketWire
03-10-17Ergomed completes acquisition of PSR StockMarketWire
03-10-17Completion of Acquisition of PSR Group BVRNS
28-09-17Ergomed conditionally raises £2.9mStockMarketWire
28-09-17Result of PlacingRNS
28-09-17Acquisition of PSR Group BV and PlacingRNS
27-09-17Commercialisation Deal on Haemostatix ProductsRNS
18-09-17Ergomed net service revenues up 53%StockMarketWire
18-09-17Interim ResultsRNS
21-08-17CEL-SCI Corporation issues restricted sharesRNS
14-08-17Ergomed's partner to resume Phase 3 study of MultikineStockMarketWire
14-08-17FDA removal of hold on Ph3 trial with MultikineRNS
14-08-17Ergomed schedules interim results StockMarketWire
14-08-17Notice of ResultsRNS
24-07-17Ergomed completes study recruitment ahead of schedule StockMarketWire
24-07-17Recruitment complete early for Phase IIb studyRNS
04-07-17Investor MeetingRNS
21-06-17PeproStat study passes recruitment mid-pointRNS
19-06-17Ergomed resolutions passed at AGMStockMarketWire
16-06-17Result of AGMRNS
16-06-17Ergomed appoints CEOStockMarketWire
16-06-17Appointment of CEORNS
13-06-17Ergomed to present at the Shares Spotlight Evening in Manchester on 29 June 2017StockMarketWire
22-05-17Appointment of N+1 Singer as joint brokerRNS
12-05-17Annual Report and Notice of AGMRNS
08-05-17Ergomed updates in PharmInvent earn-outStockMarketWire
08-05-17Issue of Shares to Former PharmInvent ShareholdersRNS
02-05-17Broker Forecast - Stifel issues a broker note on Ergomed PlcStockMarketWire
02-05-17Broker Forecast - Numis issues a broker note on Ergomed PlcStockMarketWire
02-05-17Co-Development Partner NewsRNS
26-04-1711 shares where positive earnings shocks could trigger ralliesInteractive Investor
13-04-17Board and Management ChangesRNS
04-04-17Director Deals - Ergomed Plc (ERGO)StockMarketWire
04-04-17Director/PDMR ShareholdingRNS
03-04-17Ergomed partner announces successful dataStockMarketWire
03-04-17Partner Asarina Pharma announces successful dataRNS
28-03-17Ergomed revenues up 30%StockMarketWire
28-03-17Ergomed revenues up StockMarketWire
28-03-17Unaudited Preliminary Results for 2016RNS

RSS feeds

  • Editorial news feed for LSE:ERGO Editorial
  • Regulatory news feed for LSE:ERGO Regulatory